K. Halmschlag

Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.

R. Voll, N. Frede, U. Salzer, 2017, The journal of allergy and clinical immunology. In practice.

Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.

R. Voll, N. Frede, U. Salzer, 2017, The journal of allergy and clinical immunology. In practice.